Russell Investments Group’s Rhythm Pharmaceuticals RYTM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.28M | Buy |
130,998
+16,220
| +14% | +$1.02M | 0.01% | 933 |
|
|
2025
Q1 | $6.08M | Buy |
114,778
+113,781
| +11,412% | +$6.03M | 0.01% | 1056 |
|
|
2024
Q4 | $55.8K | Buy |
997
+3
| +0.3% | +$168 | ﹤0.01% | 2795 |
|
|
2024
Q3 | $52.1K | Sell |
994
-1,016
| -51% | -$53.2K | ﹤0.01% | 2783 |
|
|
2024
Q2 | $82.5K | Buy |
2,010
+1,625
| +422% | +$66.7K | ﹤0.01% | 2665 |
|
|
2024
Q1 | $16.7K | Buy |
+385
| New | +$16.7K | ﹤0.01% | 2794 |
|
|
2023
Q3 | – | Sell |
-1,100
| Closed | -$18.1K | – | 3613 |
|
|
2023
Q2 | $18.1K | Buy |
+1,100
| New | +$18.1K | ﹤0.01% | 2857 |
|
|
2020
Q4 | – | Sell |
-5,891
| Closed | -$127K | – | 3173 |
|
|
2020
Q3 | $127K | Buy |
+5,891
| New | +$127K | ﹤0.01% | 2927 |
|
|
2019
Q2 | – | Sell |
-37,754
| Closed | -$1.04M | – | 2939 |
|
|
2019
Q1 | $1.04M | Buy |
37,754
+3,192
| +9% | +$87.7K | ﹤0.01% | 2045 |
|
|
2018
Q4 | $929K | Sell |
34,562
-3,098
| -8% | -$83.3K | ﹤0.01% | 2005 |
|
|
2018
Q3 | $1.1M | Sell |
37,660
-21,243
| -36% | -$620K | ﹤0.01% | 2060 |
|
|
2018
Q2 | $1.84M | Sell |
58,903
-8,523
| -13% | -$266K | ﹤0.01% | 1803 |
|
|
2018
Q1 | $1.34M | Buy |
+67,426
| New | +$1.34M | ﹤0.01% | 2059 |
|